ALLO

Allogene Therapeutics Inc

Jun 22 • 04:00PM ET

2.10

+0.10 5.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SANA KRYS BMRN RYTM KYMR INCY NUVL VKTX AXSM NBIX

| Held by: XBI VTI IWM VXF IBB KOMP FESM IWN SCHA DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	24.61%	Shs Outstand	345.15M	Perf Week	10.53%
Market Cap	724.81M	Forward P/E	-	EPS next Y	-0.75	Insider Trans	-0.34%	Shs Float	260.21M	Perf Month	10.53%
Enterprise Value	538.97M	PEG	-	EPS next Q	-0.17	Inst Own	39.01%	Short Float	17.09%	Perf Quarter	1.45%
Income	-173.76M	P/S	-	EPS this Y	19.26%	Inst Trans	7.12%	Short Ratio	4.28	Perf Half Y	47.89%
Sales	0.00M	P/B	1.84	EPS next Y	-6.71%	ROA	-38.45%	Short Interest	44.48M	Perf YTD	53.28%
Book/sh	1.14	P/C	2.72	EPS next 5Y	7.44%	ROE	-52.32%	52W High	4.46 -52.91%	Perf Year	70.73%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-49.43%	52W Low	0.98 113.37%	Perf 3Y	-55.32%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.90% 6.59%	Perf 5Y	-91.23%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	37.45%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	54.47	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	36.09%	SMA20	4.90%	Beta	0.47	Target Price	8.48
Payout	-	Debt/Eq	0.29	Sales Q/Q	-	SMA50	-2.49%	Rel Volume	0.63	Prev Close	2.00
Employees	152	LT Debt/Eq	0.26	Earnings	May 13 AMC	SMA200	19.13%	Avg Volume	10.39M	Price	2.10
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.31% -100.00%	Trades		Volume	6,569,732	Change	5.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)